News

Orangekloud and ELITC Join Forces for No-Code App Development

Orangekloud and ELITC Join Forces for No-Code App Development

Orangekloud Partners with ELITC for No-Code Training

Orangekloud Technology Inc. (NASDAQ:ORKT), well-known for its innovative no-code mobile application development platforms, has embarked on an exciting partnership with the Electronics Industries Training Centre (ELITC). This collaboration sets the stage for a transformative approach to mobile app creation without the need for extensive coding training.

Boosting Workforce Digital Skills

The primary goal of the Orangekloud and ELITC partnership is to enhance the digital capabilities of the workforce. By focusing on the eMOBIQ No-code platform, the initiative is aimed at individuals eager to craft mobile applications without prior coding knowledge. This partnership not only empowers trainees but also supports local businesses in their digital transformation journey.

Extensive Network and Industry Reach

ELITC's considerable outreach to training networks is expected to significantly bolster the adoption of Orangekloud's eMOBIQ solutions. Enterprises operating within the electronics industry, along with various other sectors, will now have access to tools that can improve their efficiency in areas such as sales and inventory management. This is particularly crucial for businesses aiming to keep pace with digital innovations.

eMOBIQ Platform Overview

The eMOBIQ platform is specifically designed to cater to the needs of Small and Medium Enterprises (SMEs) and larger corporations. It encompasses a range of applications aimed at streamlining and digitizing various business processes. Various industries, including food production, precision engineering, and retail, have already started benefiting from the functionalities offered by Orangekloud's platform.

ELITC's Role in Workforce Development

As a prominent institution in Singapore, ELITC plays a vital role in providing training programs that support government initiatives for workforce upskilling and reskilling. For individuals entering the job market, ELITC facilitates the acquisition of essential digital skills that are increasingly important in today's tech-driven landscape.

Strategic Implications for Orangekloud

This partnership is strategically significant for Orangekloud. By leveraging ELITC's training capabilities and expansive network, they effectively promote their no-code platform while fostering a skilled workforce adept at utilizing digital tools. This focus on education and empowerment reflects the company’s commitment to innovation and cultivation of expertise in the technology space.

Recent Developments and Future Outlook

In addition to the partnership with ELITC, Orangekloud has made headlines with a significant investment in Singapore cybersecurity firm Evvo Labs. This initiative is designed to strengthen its digital transformation offerings and enhance product capabilities. Furthermore, Orangekloud’s collaboration with AI Singapore (AISG) seeks to streamline app development processes, allowing even those without coding experience to create effective applications.

Financial Position and Market Performance

As the company forges ahead with its strategic initiatives, a review of its financial standing reveals some interesting insights. Currently, Orangekloud holds a market capitalization of $174.27 million. In recent months, the stock has experienced a notable increase of 53.82%, a trend that positions it near its 52-week high.

Despite this positive momentum, investors are advised to proceed with caution as market indicators suggest the stock might be overbought. Additionally, with a moderate level of debt, financial flexibility could be a concern as the company continues to expand its eMOBIQ platform through beneficial partnerships like that of ELITC.

Frequently Asked Questions

What is the purpose of the Orangekloud and ELITC partnership?

The partnership focuses on enhancing workforce digital competencies by providing training on the eMOBIQ No-code platform for creating mobile applications.

What industries can benefit from the eMOBIQ platform?

The eMOBIQ platform is beneficial for various industries including food manufacturing, precision engineering, retail, and warehouse management.

What is ELITC's role in this partnership?

ELITC serves as a training partner, offering programs aimed at equipping individuals with the skills to utilize the eMOBIQ platform effectively.

How has Orangekloud's stock performed recently?

Orangekloud's stock has experienced a significant increase of 53.82%, bringing it close to its 52-week high.

What other recent developments has Orangekloud announced?

Orangekloud announced an investment in Evvo Labs and partnered with AI Singapore to enhance app development processes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading